Exploring TKIs in metastatic sarcomas: Results of REGOBONE osteosarcoma cohort
Professor Jean-Yves Blay and Professor Florence Duffaud
Exploring TKIs in metastatic sarcomas: Results of REGOBONE osteosarcoma cohort ( Professor Jean-Yves Blay and Professor Florence Duffaud )
14 Nov 2019
REGOSARC – activity of regorafenib in advanced non-adipocytic STS
Professor Jean-Yves Blay and Professor Florence Duffaud
REGOSARC – activity of regorafenib in advanced non-adipocytic STS ( Professor Jean-Yves Blay and Professor Florence Duffaud )
14 Nov 2019
The cancer groundshot: Going global before going to the moon
Dr Bishal Gyawali - Queen's University, Kingston, Canada
The cancer groundshot: Going global before going to the moon ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
7 Nov 2019
Analysis of assay used in IMpassion130 to guide treatment of metastatic and adva...
Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
Analysis of assay used in IMpassion130 to guide treatment of metastatic and advanced breast cancers ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
31 Oct 2019
Treatment pathways for patients with triple-negative breast cancer
Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA
Treatment pathways for patients with triple-negative breast cancer ( Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA )
23 Oct 2019
PARP inhibitors in metastatic breast cancer: The present and the future
Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA
PARP inhibitors in metastatic breast cancer: The present and the future ( Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA )
23 Oct 2019
The treatment landscape of occular melanoma
Maitry Patel CCPA - Princess Margaret Cancer Centre, Toronto, Canada
The treatment landscape of occular melanoma ( Maitry Patel CCPA - Princess Margaret Cancer Centre, Toronto, Canada )
21 Oct 2019
Immunotherapy in gastric cancers
Dr. Manish A. Shah - Mayo Clinic, Rochester, USA
Immunotherapy in gastric cancers ( Dr. Manish A. Shah - Mayo Clinic, Rochester, USA )
21 Oct 2019
Comment: Use of biosimilar monoclonal antibodies in the clinic
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Use of biosimilar monoclonal antibodies in the clinic ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
VOLFI: FOLFOXIRI and panitumumab in RAS wild-type metastatic colorectal cancer
Dr Dominik Modest - Charité Universitätsmedizin Berlin, Berlin, Germany
VOLFI: FOLFOXIRI and panitumumab in RAS wild-type metastatic colorectal cancer ( Dr Dominik Modest - Charité Universitätsmedizin Berlin, Berlin, Germany )
7 Oct 2019
CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resist...
Prof Ronald de Wit - Erasmus University Medical Center, Rotterdam, Netherlands
CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer ( Prof Ronald de Wit - Erasmus University Medical Center, Rotterdam, Netherlands )
7 Oct 2019
Niraparib therapy in patients with newly diagnosed advanced ovarian cancer
Dr Antonio González-Martín - Clínica Universidad de Navarra, Madrid, Spain
Niraparib therapy in patients with newly diagnosed advanced ovarian cancer ( Dr Antonio González-Martín - Clínica Universidad de Navarra, Madrid, Spain )
7 Oct 2019